4HBP

Target information

RCSB PDB
4HBP
Title
Crystal Structure of FAAH in complex with inhibitor
Method
X-RAY DIFFRACTION
Resolution
2.91
Classification
HYDROLASE/HYDROLASE INHIBITOR
Organism
Rattus norvegicus
Protein
Fatty-acid amide hydrolase 1 (P97612)    Looking for covalent inhibitors of this target ?
Year
2012
Publication Title
Synthesis, SAR study, and biological evaluation of a series of piperazine ureas as fatty acid amide hydrolase (FAAH) inhibitors.
Abstract

A series of piperazine ureas was designed, synthesized, and evaluated for their potential as novel orally available fatty acid amide hydrolase (FAAH) inhibitors that are therapeutically effective against pain. We carried out an optimization study of the lead compound 3 to improve its DMPK profile as well as in vitro potency. We identified the thiazole compound 60j with potent inhibitory activity, high brain permeability, and good bioavailability. Compound 60j showed a potent and dose-dependent anti-nociceptive effect in the acetic acid-induced writhing test in mice.

External Link
RCSB PDB





Ligand information

HET
17J
Chain ID
A
HET Number
600
Molecular Formula
C18H18N6OS
Structure
2D structure
IUPAC Name
4-(3-phenyl-1,2,4-thiadiazol-5-yl)-N-(3-pyridyl)piperazine-1-carboxamide
InChI
InChI=1S/C18H18N6OS/c25-17(20-15-7-4-8-19-13-15)23-9-11-24(12-10-23)18-21-16(22-26-18)14-5-2-1-3-6-14/h1-8,13H,9-12H2,(H,20,25)
InChI Key
RCAFZHFLIBYWGO-UHFFFAOYSA-N
Canonical SMILES
O=C(Nc1cccnc1)N1CCN(c2nc(-c3ccccc3)ns2)CC1
Bioactivity data
CI000512

Covalent Binding

Warhead
Urea carbonyl
Reaction Mechanism
Nucleophilic Substitution
Residue
SER : 241
Residue Chain
A
Interactions
Pharmacophore Model